RT @KDAO2011: Anifrolumab pooled TULIP-1&-2 data on rash and arthritis in SLE more effective in pts with high IFN si
Tweet Content
Anifrolumab pooled TULIP-1&-2 data on rash and arthritis in SLE more effective in pts with high IFN signals (pts with low IFN may benefit, but they had less rash but more arthritis)- Dr. J Merrill #OP0131 #EULAR2021 @rheumnow
Show on Archive Page
On
Display in Search Results
On
PDQ
Off